Latest News from: FAST (Foundation for Angelman Syndrome Therapeutics)

Filters close
Released: 14-Dec-2020 9:15 AM EST
FAST Conference Draws 20 Pharmaceutical Companies and Raises Over $2.2 Million for Research on Angelman Syndrome
FAST (Foundation for Angelman Syndrome Therapeutics)

FAST (the Foundation for Angelman Syndrome Therapeutics) today announced that Virtually Unstoppable, their annual Summit & Gala benefitting Angelman syndrome (AS) raised over $2.2 million during their virtual two-day conference.

Released: 14-Feb-2017 3:05 PM EST
Penn Gene Therapy Pioneer Teams Up with FAST in Race to Cure Angelman Syndrome
FAST (Foundation for Angelman Syndrome Therapeutics)

A pioneer on the frontier of genetic medicine and his team at one of the nation’s top-five medical research schools have joined forces with FAST (Foundation for Angelman Syndrome Therapeutics) to develop a treatment for the rare disorder Angelman syndrome.


  • Previous Page
  • Next Page

Showing results

12 of 2

close
0.07043